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Introduction: Hyponatremia associated with rhabdomyolysis is a rare event and a correct diagnostic approach is
required to rule out this or other diseases as a primary cause and to avoid other complications resulting from a lack
of appropriate treatment.
Case presentation: A 64-year-old Caucasian woman presented to our facility with worsening fatigue, slurred
speech, nausea and vomiting, and high serum levels of creatine kinase and myoglobin together with hyponatremia.
Normal arterial blood gas analysis results, normal serum potassium levels, increased urine sodium levels, urine
specific gravity of >1003N/m3 and low urine volume suggested an endocrine etiology. Her low cortisol and thyroid
hormone serum levels suggested a pituitary disorder. A magnetic resonance imaging study showed atrophy of her
pituitary gland. A more detailed study of our patient’s obstetric history revealed a post-partum hemorrhage 30
years earlier. She was diagnosed as having late-onset Sheehan’s syndrome and treated with hormone replacement
therapy, which normalized her clinical picture.
Conclusions: This case report shows that, in hyponatremia-associated rhabdomyolysis, an endocrinological origin
should always be considered. This should include Sheehan’s syndrome as it can occur with late onset.Introduction
Hyponatremia is an event frequently found in clinical
practice that physicians are often called upon to deal
with, and it often results in complications including
rhabdomyolysis [1]. In such cases in particular, a correct
diagnostic approach is required to rule out this or other dis-
eases as a primary cause and to avoid other complications
resulting from a lack of appropriate treatment.
Here, we describe a case of rhabdomyolysis and
hyponatremia with an infrequent endocrine etiology.Case presentation
A 64-year-old Caucasian woman was admitted to our
Internal Medicine Unit for worsening fatigue, slurred
speech, nausea and vomiting. In our Emergency Room
she had been treated with saline solution infusion for
hyponatremia (121mEq/L). Her clinical history showed
nothing relevant until the age of 34, when she underwent* Correspondence: lydiagiannitp@gmail.com
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reproduction in any medium, provided the ora hysterectomy following post-partum complications; she
had previously carried three pregnancies to term without
complications. Thirty years later, a few months before her
current admission, she began to experience fatigue, mental
lethargy, myalgia and leg cramps, which were empirically
treated with multivitamin supplements. She declined to
undergo any further voluntary diagnostic evaluations,
especially since the symptoms had partially improved.
However, the onset of dysarthria, nausea and vomiting
brought her to our Emergency Department.
As a cerebrovascular disease was suspected, a brain
computed tomography (CT) scan without contrast medium
was performed, which was within normal limits. The results
of a physical examination revealed no neurological deficits
except for the alteration in speech. Her skin was dry, her
armpit hair was thinning and was reported by our patient
to have been reduced for several years. Her hemodynamic
and glycol-metabolic patterns were compensated. There
were no clinical alterations in the thoracic or abdominal
areas and no evidence of dehydration of the mucous
membranes or peripheral edema. Table 1 shows the
laboratory findings at presentation to hospital. Abdominaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Laboratory test results at presentation to hospital and at one and two weeks later
Presentation Week one Week two Reference values
Blood urea nitrogen, mg/dL 28 20 33 10 to 50
Creatinine, mg/dL 0.83 0.78 0.9 0.6 to 1.0
Sodium, mEq/L 129 132 138 135 to 145
Potassium, mEq/L 4.75 4.6 4.5 3.5 to 5
Chlorine, mEq/L 92 98 105 95 to 108
Glucose, mg/dL 61 70 75 70 to 110
Cholesterol, mg/dL 310 300 222 <180
High-density lipoprotein, mg/dL 45 43 49 40 to 85
Triglycerides, mg/dL 172 180 150 <190
Glutamic oxaloacetic transaminase, U/L 123 58 41 7 to 34
Glutamic pyruvic transaminase, U/L 60 29 28 8 to 50
Creatine kinase, U/L 1377 678 292 40 to 300
Lactate dehydrogenase, U/L 1023 950 605 240 to 450
Myoglobin, ng/mL 1150 380 88 <90
Uric acid, mg/dL 2.9 2.4 2.7 2.3 to 6
Plasma osmolarity, mOsm/L 277 280 292 280 to 300
Urine:
Specific gravity, N/m3 1005 1009 1010 1003 to 1030
Osmolarity, mOsm/L 175 315 350 105 to 1050
pH 7 7.5 6.5 4.5 to 7
Urine sodium, mEq/L/24 hours 93 142 130 50 to 250
Urine potassium, mEq/L/24 hours 16 30 45 30 to 110
Hormones:
Free tri-iodothyronine, pg/mL 0.6 1 2.0 to 4.4
Free thyroxine, ng/dL 0.06 0.21 0.93 to 1.7
Thyroid-stimulating hormone, uIU/mL 1.56 2.19 0.27 to 4.2
Adrenocorticotropic hormone, pg/mL (8.00 am) 17 - 7.2 to 63.3
Cortisol, μg/mL 1.4 - 6.2 to 19
Prolactin, ng/mL 1.41 - 4.79 to 23.3
Follicle-stimulating hormone, mIU/mL 7.04 - 25.8 to 134
Luteinizing hormone, mIU/mL 3.0 - 7.7 to 58.5
One-week values are without hormone therapy. Two-week values are with cortisone acetate therapy.
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presence of myalgia and high creatine kinase (CK) and
myoglobin values suggested rhabdomyolysis without renal
involvement [2]. The lack of statin treatment or history
of alcohol consumption together with the absence of
trauma suggested that the rhabdomyolysis was related
to hyponatremia or an immunological disorder. Specific
autoantibody assay results, however, were negative. The
association of hyponatremia with normal arterial
blood gas analysis, normal serum potassium, normal
urine sodium, urine specific gravity >1003N/m3 and
urine osmolarity 174mOsm/L excluded polydipsia and
suggested an endocrine etiology: hypocortisolism or
hypothyroidism. Urine osmolality lower than serum valuesexcluded syndrome of inappropriate anti-diuretic hormone
hypersecretion (SIADH) [3,4]. Reduced levels of free
circulating fractions of thyroid hormones associated
with a thyroid-stimulating hormone (TSH) value inappro-
priately within the normal range indicated a possible thy-
roid and/or an anterior pituitary gland endocrine disorder
[5,6]. As her cortisol levels were low, her adrenocorticotro-
pic hormone (ACTH) level was measured, but this was
within the normal range. In addition, low levels of prolactin
(PRL), luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) left little doubt as to the diagnosis. A
pituitary genesis also seemed plausible because of our
patient’s medical history, which suggested late-onset
Sheehan’s syndrome [7,8]. To confirm this hypothesis,
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was further discussed with her. She could not recall
the precise details but remembered bleeding that had
required numerous blood transfusions. In addition,
our patient was not able to give a detailed description
of lactation and she had not breast fed on medical
advice, probably due to the post-hysterectomy medical
treatment.
Magnetic resonance imaging with contrast medium
showed a marked decrease in pituitary gland size
(Figure 1) with signs of a chronic deficit in frontal
cortical flow and a small cortical malacia. Cortisone
acetate therapy was started at a dose of 25mg in the
morning and 12.5mg after six hours. After the first
two weeks L-thyroxin replacement treatment at a
dose of 1.6μg/kg body weight was added. Her clinical
symptoms and laboratory abnormalities resolved and
serum sodium levels and myolysis indices normalized
after five days. Given the age of our patient, estrogen
replacement therapy was not necessary.
Discussion
Atrophy of the pituitary gland was interpreted in our
patient’s case as a likely outcome of late-onset Sheehan’s
syndrome, a consequence of a post-partum hemorrhage
that our patient was able to recall.
Sheehan first described pituitary infarction and
panhypopituitarism after a post-partum hemorrhage
in 1938, but the mechanism of ischemia is still not
entirely clear. Hypotension and subsequent pituitary
arterial vasospasm seem to compromise blood perfusion
in the pituitary gland, causing its necrosis. Signs of
hypopituitarism are reported in 32 percent of women
with severe post-partum hemorrhage. The rapidity of
onset and degree of pituitary insufficiency depend on
the extent of the damage. The gland, however, has a
high reserve and more than 75 percent of the pituitary
needs to be damaged before clinical manifestations areFigure 1 Coronal (A) and sagittal (B) T1-weighted magnetic resonanc
gland. The pituitary fossa appears normal in size. The pituitary stalk is well sevident. The first of these appears to be the absence
of lactation after delivery. Although a small percentage of
patients with Sheehan’s syndrome present with severe
hypopituitarism immediately after labor, in many patients
it remains undiagnosed and the pituitary failure is only
recognized and treated after many years [7,8], as in our
patient’s case. CT and magnetic resonance imaging (MRI)
in most cases indicate an etiologic diagnosis. Imaging
results show an empty sella and an atrophic gland, as in our
patient. The MRI results also showed signs of chronic flow
deficits, which could to some extent justify the syndrome
manifestation as a result of the progressive loss of
residual functional reserve. Another condition considered
was lymphocytic hypophysitis, related to pregnancy in most
of the women studied. There are in fact many similarities
between Sheehan’s syndrome and lymphocytic hypophysitis,
which is an autoimmune disease seen in both sexes.
However, in our patient’s case the absence of clinical
signs and serological markers of autoimmunity, together
with the obstetric history and the imaging results,
excluded this diagnosis [9].
A diagnosis of secondary hypothyroidism was suggested
by the low free tri-iodothyronine (fT3) and free thyroxine
(fT4) levels, with values inappropriately within the normal
range or below the standard in the case of TSH [6]; but
fT3 and fT4 levels were almost 0, excluding euthyroid sick
syndrome [10].
Although secondary hypothyroidism appears to be a
rare condition it must always be considered when there
is a similar hormonal pattern, particularly in younger
individuals without acute or chronic thyroid disease.
Our patient’s case demonstrates the importance of a
correct differential diagnosis that does not overlook
medical history clues or signs that seem to be of
minor importance. However, it also emphasizes the
essential role of state-of-the-art laboratory tests and diag-
nostic imaging. Specifically, comparative assessments of
blood and urine tests allowed us to correctly choosee imaging. Images show marked diminution in the size of the pituitary
een and correctly oriented.
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evaluation suggested a solely pituitary genesis and the
accuracy of MRI indicated the organic etiology of the
syndrome event. Regarding the therapeutic approach,
replacement therapy re-established a satisfactory physical
and mental well-being, although recent cohort studies
have shown an increased mortality in patients with hypo-
pituitarism despite treatment [11]. It must be underlined
that before the hormone replacement therapy was started
there was a partial resolution of rhabdomyolysis, as shown
by a modest decrease in the necrosis indices, likely due to
the correction of hyponatremia following the administra-
tion of hypersaline solutions. Hyponatremia is one of the
spectrum of conditions that can lead to rhabdomyolysis,
and in our patient’s case there may have also been an elec-
trolyte imbalance in addition to the endocrine genesis.
The literature offers various data to support this hypoth-
esis [1]. However, only with the hormone replacement
therapy was it possible to obtain a fluid and electrolyte
balance and a reduction in the indices of cytolysis and
rhabdomyolysis to within normal values.
Several mechanisms are responsible for hyponatremia
in Sheehan’s syndrome: hypothyroidism, glucocorticoid
deficiency, volume depletion, and SIADH. Moreover,
both adrenal insufficiency and hypothyroidism can lead
to myopathy.
In our patient, steroid therapy alone normalized her
serum sodium, CK and myoglobin levels. Therefore, we
believe that adrenal insufficiency was the main cause of the
hyponatremia and rhabdomyolysis. However, an association
between hypothyroidism and severe hyponatremia is also
known, mainly due to an increased release of anti-diuretic
hormone (ADH) caused by a reduced sensitivity of the
osmoreceptors to reductions in plasma osmolality [12].
With regard to metabolic alterations, in particular
hyperlipemia, treatment with thyroid hormones com-
pletely corrected hypertriglyceridemia and reduced the
hypercholesterolemia recorded at entrance.
Our patient has now been placed on a six-month
out-patient follow-up to monitor her clinical status and to
allow any necessary adjustments to the treatment.
Conclusions
The present report shows that in hyponatremia-associated
rhabdomyolysis an endocrinological origin has always to
be considered, including Sheehan’s syndrome as it can
occur with late onset.
Several diseases can be associated with hyponatremia
and rhabdomyolysis with a poor prognosis. The present
work suggests the need for an adequate diagnostic ap-
proach based on simple and inexpensive tests (including
serum and urine laboratory tests along with arterial blood
gas analysis) that focus on the early identification of the
cause and its correct treatment.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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